Deutsche Bank’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,088,705
| Closed | -$193M | – | 4630 |
|
|
2020
Q1 | $193M | Buy |
1,088,705
+133,367
| +14% | +$25.1M | 0.17% | 117 |
|
|
2019
Q4 | $183M | Sell |
955,338
-120,702
| -11% | -$21.8M | 0.12% | 173 |
|
|
2019
Q3 | $181M | Sell |
1,076,040
-265,865
| -20% | -$43.3M | 0.13% | 162 |
|
|
2019
Q2 | $225M | Buy |
1,341,905
+255,067
| +23% | +$35.3M | 0.13% | 155 |
|
|
2019
Q1 | $159M | Sell |
1,086,838
-577,447
| -35% | -$83.7M | 0.09% | 232 |
|
|
2018
Q4 | $222M | Sell |
1,664,285
-133,093
| -7% | -$21.8M | 0.16% | 135 |
|
|
2018
Q3 | $342M | Buy |
1,797,378
+67,005
| +4% | +$12.3M | 0.17% | 116 |
|
|
2018
Q2 | $288M | Buy |
1,730,373
+292,621
| +20% | +$47M | 0.14% | 145 |
|
|
2018
Q1 | $242M | Sell |
1,437,752
-91,023
| -6% | -$15.3M | 0.12% | 182 |
|
|
2017
Q4 | $250M | Buy |
1,528,775
+447,589
| +41% | +$80.3M | 0.16% | 130 |
|
|
2017
Q3 | $222M | Sell |
1,081,186
-311,240
| -22% | -$72.4M | 0.15% | 139 |
|
|
2017
Q2 | $338M | Sell |
1,392,426
-313,993
| -18% | -$73.8M | 0.24% | 86 |
|
|
2017
Q1 | $408M | Sell |
1,706,419
-73,135
| -4% | -$17M | 0.3% | 72 |
|
|
2016
Q4 | $374M | Sell |
1,779,554
-77,678
| -4% | -$16.1M | 0.3% | 70 |
|
|
2016
Q3 | $428M | Sell |
1,857,232
-287,597
| -13% | -$70.3M | 0.3% | 73 |
|
|
2016
Q2 | $496M | Buy |
2,144,829
+302,146
| +16% | +$69.7M | 0.35% | 55 |
|
|
2016
Q1 | $494M | Buy |
1,842,683
+225,168
| +14% | +$64.5M | 0.37% | 54 |
|
|
2015
Q4 | $505M | Buy |
1,617,515
+292,733
| +22% | +$87.2M | 0.35% | 54 |
|
|
2015
Q3 | $360M | Sell |
1,324,782
-346,974
| -21% | -$107M | 0.28% | 69 |
|
|
2015
Q2 | $507M | Sell |
1,671,756
-60,719
| -4% | -$18.1M | 0.32% | 63 |
|
|
2015
Q1 | $516M | Buy |
1,732,475
+401,560
| +30% | +$114M | 0.32% | 67 |
|
|
2014
Q4 | $343M | Buy |
1,330,915
+795,492
| +149% | +$199M | 0.21% | 99 |
|
|
2014
Q3 | $129M | Sell |
535,423
-401,152
| -43% | -$89.8M | 0.08% | 278 |
|
|
2014
Q2 | $209M | Buy |
936,575
+440,635
| +89% | +$91.2M | 0.14% | 168 |
|
|
2014
Q1 | $102M | Buy |
495,940
+147,200
| +42% | +$29.2M | 0.07% | 325 |
|
|
2013
Q4 | $58.6M | Sell |
348,740
-27,633
| -7% | -$4.32M | 0.04% | 449 |
|
|
2013
Q3 | $54.2M | Buy |
376,373
+89,248
| +31% | +$11.9M | 0.04% | 471 |
|
|
2013
Q2 | $36.2M | Buy |
+287,125
| New | +$32.5M | 0.03% | 586 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Deutsche Bank's AGN Position: Q2 2020 in Review
Deutsche Bank sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,088,705 shares — an estimated $193M sold.
Deutsche Bank first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $516M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Deutsche Bank reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Deutsche Bank sold 1,088,705 Allergan plc shares in Q2 2020, an estimated $193M.
- Deutsche Bank first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Deutsche Bank's Allergan plc position peaked at $516M in Q1 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Deutsche Bank's 13F filing for Q2 2020, filed 13 Aug 2020.